← Every applicant
Hetero Labs Ltd Vi FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| METHOTREXATE SODIUMNew drugApr 30, 2026INJECTABLE, INJECTION |
| PLERIXAFORNew drugJun 16, 2025SOLUTION, SUBCUTANEOUS |
| OXALIPLATINNew drugJan 27, 2025INJECTABLE, INTRAVENOUS |
| AZACITIDINENew drugOct 15, 2024POWDER, INTRAVENOUS, SUBCUTANEOUS |
| PEMETREXED DISODIUMNew drugJun 14, 2024POWDER, INTRAVENOUS |
| DECITABINENew drugMay 10, 2024INJECTABLE, INTRAVENOUS |
| BORTEZOMIBNew drugMay 3, 2024INJECTABLE, INTRAVENOUS, SUBCUTANEOUS |